Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals

NCT04871165 is registered in ClinicalTrials.gov with Vilnius University as lead sponsor.

NCT NCT04871165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Lead sponsor
Vilnius University
Phase
Observational
Overall status
Unknown status
Start date
March 24, 2021
Completion date
March 1, 2024
Enrollment
3,270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines, hematologic neoplasms